Perioperative administration of tranexamic acid in hip fracture surgery (The PATHS study): national audit of current practice.
Andrew J BergThomas Andrew NaylorDavid Sands Johnsonnull nullPublished in: Annals of the Royal College of Surgeons of England (2022)
Despite supportive evidence for its use, a wide variation in the administration of TXA between hospitals and procedures has been demonstrated. Administration rates were higher for arthroplasty than for fixation procedures. Most centres do not have a protocol guiding TXA administration. We recommend administration of 1g IV TXA perioperatively for patients undergoing NOFF surgery, where not contraindicated, unless future randomised controlled trials support an alternative regimen. We recommend units include their own locally agreed TXA policy within a written protocol for the care of NOFF patients.
Keyphrases
- healthcare
- minimally invasive
- patients undergoing
- hip fracture
- quality improvement
- end stage renal disease
- randomized controlled trial
- coronary artery bypass
- public health
- newly diagnosed
- primary care
- chronic kidney disease
- mental health
- peritoneal dialysis
- pain management
- patient reported outcomes
- atrial fibrillation
- patient reported